RAP-219
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 04/02/2025
Pipeline Type
New Drugs in Development
Phase Of Development
Phase 2
Sponsors and Collaborators
RAPPORT THERAPEUTICS
Mechanism of Action
Neuromodulation
Mechanism Description
TARPý8
Populations Tested In
N/A
Other Resources
Special FDA Designation
None
Nonprofit or Government Support
Other
Nonprofit or Government Support Description
Previous Presentations
Location of Clinical Trials
usa
Clinical Trial link